Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.21.1
Stockholders’ Equity (Tables)
 9 Months Ended
Apr. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of amounts of share-based compensation expense
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2021     2020     2021     2020  
Stock options and performance stock units   $ 297     $ 206     $ 638     $ 724  
Restricted stock     —       1       2       4  
    $ 297     $ 207     $ 640     $ 728  
Schedule of share-based payment arrangement
    Three months ended
April 30,		     Nine months ended
April 30,		  
    2021     2020     2021     2020  
Selling, general and administrative   $ 258     $ 207     $ 574     $ 728  
Cost of revenues     39       —       66       —  
    $ 297     $ 207     $ 640     $ 728  
Schedule of stock option activity
    Options     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value
(000s)		  
Outstanding at July 31, 2020     2,636,496     $ 4.05                  
Awarded     543,104     $ 2.57                  
Exercised     (34,667 )     2.80             $  
Expired or forfeited     (619,371 )   $ 3.40                  
Outstanding at end of period     2,525,562     $ 3.76       2.6 years     $ 957  
Exercisable at end of period     1,581,326     $       1.6 years     $  
Schedule of nonvested performance-based units activity
Grant Date   Total Grant     Forfeitures     Outstanding     Fair Market Value At Grant Date (000s)  
10/15/2018     32,000       (6,000 )     26,000     $ 107  
10/15/2019     80,500       (14,500 )     66,000     $ 222  
10/19/2020     98,600       —       98,600     $ 207